Literature DB >> 9399516

Fecal microflora in a patient with short-bowel syndrome and identification of dominant lactobacilli.

T Kaneko1, Y Bando, H Kurihara, K Satomi, K Nonoyama, N Matsuura.   

Abstract

Fecal microflora and lactate concentrations in blood and feces obtained from a patient (a 5 year-old boy) with short-bowel syndrome (SBS) were compared during acidosis to results for the normal condition (no SBS symptoms). The taxonomical position of the lactobacilli found predominantly in the feces sample obtained 2 days before the fifth attack was also studied. The D-lactate level in serum obtained 1 day after the fourth attack was 10-fold higher than that for the normal condition, although there was not a great difference in L-lactate levels. D-Lactate (3.91 mM) and L-lactate (2.86 mM) were also detected in the feces samples collected 2 days before the fifth attack, while no lactate was detected in the feces sample for the normal condition. The counts of total fecal bacteria, especially anaerobic bacteria such as members of the family Bacteroidaceae, were found to be low. The counts of lactobacilli and the total population of lactobacilli relative to total fecal bacteria in the feces 2 days before the fifth attack (40.4%) were extremely high. In this case, a majority of the lactobacilli were D-lactate producers as determined by homolactic fermentation. These lactobacilli were identified as Lactobacillus delbrueckii subsp. lactis. The percentages of bifidobacteria relative to total fecal bacteria in feces samples obtained both 2 days before the fifth attack (50.9%) and for normal condition (61.9%) were also high, although these bacteria were L-lactate producers. In the feces samples for the normal condition, the D-lactate producers decreased to less than 10(9) per g, while the counts of L- or DL-lactate producers were 100-fold higher than the numbers in feces samples obtained 2 days before the fifth attack. These results suggested that an increase in the level of D-lactate producers, such as L. delbrueckii subsp. lactis, in the colon may be associated with the clinical expression of metabolic acidosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9399516      PMCID: PMC230144          DOI: 10.1128/jcm.35.12.3181-3185.1997

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  27 in total

1.  Reverse dot blot hybridization: a useful method for the direct identification of lactic acid bacteria in fermented food.

Authors:  M Ehrmann; W Ludwig; K H Schleifer
Journal:  FEMS Microbiol Lett       Date:  1994-04-01       Impact factor: 2.742

2.  [Improved methodology of qualitative and quantitative analysis of the intestinal flora of man and animals].

Authors:  T Mitsuoka; T Sega; S Yamamoto
Journal:  Zentralbl Bakteriol Orig       Date:  1965-03

3.  Growth stimulator for bifidobacteria produced by Propionibacterium freudenreichii and several intestinal bacteria.

Authors:  T Kaneko; H Mori; M Iwata; S Meguro
Journal:  J Dairy Sci       Date:  1994-02       Impact factor: 4.034

4.  Identification of lactobacilli from sourdough and description of Lactobacillus pontis sp. nov.

Authors:  R F Vogel; G Böcker; P Stolz; M Ehrmann; D Fanta; W Ludwig; B Pot; K Kersters; K H Schleifer; W P Hammes
Journal:  Int J Syst Bacteriol       Date:  1994-04

5.  D-lactate dehydrogenase is a member of the D-isomer-specific 2-hydroxyacid dehydrogenase family. Cloning, sequencing, and expression in Escherichia coli of the D-lactate dehydrogenase gene of Lactobacillus plantarum.

Authors:  H Taguchi; T Ohta
Journal:  J Biol Chem       Date:  1991-07-05       Impact factor: 5.157

6.  Colonic lactate metabolism and D-lactic acidosis.

Authors:  H Hove; P B Mortensen
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

7.  D-lactic acidemia and aciduria in pediatric and adult patients with short bowel syndrome.

Authors:  G Bongaerts; J Tolboom; T Naber; J Bakkeren; R Severijnen; H Willems
Journal:  Clin Chem       Date:  1995-01       Impact factor: 8.327

8.  Design and evaluation of Bacteroides DNA probes for the specific detection of human fecal pollution.

Authors:  C A Kreader
Journal:  Appl Environ Microbiol       Date:  1995-04       Impact factor: 4.792

9.  Fecal lactate and short bowel syndrome.

Authors:  D Bustos; S Pons; J C Pernas; H Gonzalez; M I Caldarini; K Ogawa; J A De Paula
Journal:  Dig Dis Sci       Date:  1994-11       Impact factor: 3.199

10.  Antibiotic-induced D-lactic acidosis.

Authors:  B E Coronado; S M Opal; D C Yoburn
Journal:  Ann Intern Med       Date:  1995-06-01       Impact factor: 25.391

View more
  11 in total

1.  Lactate-utilizing bacteria, isolated from human feces, that produce butyrate as a major fermentation product.

Authors:  Sylvia H Duncan; Petra Louis; Harry J Flint
Journal:  Appl Environ Microbiol       Date:  2004-10       Impact factor: 4.792

Review 2.  Quantifying the metabolic activities of human-associated microbial communities across multiple ecological scales.

Authors:  Corinne F Maurice; Peter J Turnbaugh
Journal:  FEMS Microbiol Rev       Date:  2013-04-22       Impact factor: 16.408

Review 3.  Examining clinical similarities between myalgic encephalomyelitis/chronic fatigue syndrome and D-lactic acidosis: a systematic review.

Authors:  Amy Wallis; Michelle Ball; Sandra McKechnie; Henry Butt; Donald P Lewis; Dorothy Bruck
Journal:  J Transl Med       Date:  2017-06-07       Impact factor: 5.531

4.  Microbiota Is Involved in Post-resection Adaptation in Humans with Short Bowel Syndrome.

Authors:  Laura Gillard; Camille Mayeur; Véronique Robert; Isabelle Pingenot; Johanne Le Beyec; André Bado; Patricia Lepage; Muriel Thomas; Francisca Joly
Journal:  Front Physiol       Date:  2017-04-19       Impact factor: 4.566

Review 5.  Support for the microgenderome invites enquiry into sex differences.

Authors:  Amy Wallis; Henry Butt; Michelle Ball; Donald P Lewis; Dorothy Bruck
Journal:  Gut Microbes       Date:  2016-11-03

6.  Bacterial profile of infant feces associated with lactation infectious breasts.

Authors:  Yuko Tsunoda; Takashi Asahara; Koji Nomoto; Yukiko Yoshioka; Eisuke Fukuma
Journal:  Pediatric Health Med Ther       Date:  2018-12-05

Review 7.  Of men in mice: the development and application of a humanized gnotobiotic mouse model for microbiome therapeutics.

Authors:  John Chulhoon Park; Sin-Hyeog Im
Journal:  Exp Mol Med       Date:  2020-09-10       Impact factor: 8.718

8.  Comparative genome analysis of Megasphaera sp. reveals niche specialization and its potential role in the human gut.

Authors:  Sudarshan Anand Shetty; Nachiket Prakash Marathe; Vikram Lanjekar; Dilip Ranade; Yogesh S Shouche
Journal:  PLoS One       Date:  2013-11-18       Impact factor: 3.240

Review 9.  Disruptions of the intestinal microbiome in necrotizing enterocolitis, short bowel syndrome, and Hirschsprung's associated enterocolitis.

Authors:  Holger Till; Christoph Castellani; Christine Moissl-Eichinger; Gregor Gorkiewicz; Georg Singer
Journal:  Front Microbiol       Date:  2015-10-16       Impact factor: 5.640

Review 10.  Extensive Intestinal Resection Triggers Behavioral Adaptation, Intestinal Remodeling and Microbiota Transition in Short Bowel Syndrome.

Authors:  Camille Mayeur; Laura Gillard; Johanne Le Beyec; André Bado; Francisca Joly; Muriel Thomas
Journal:  Microorganisms       Date:  2016-03-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.